Nutrien maintains strong outlook with strategic shifts despite slight EPS miss, CIBC keeps 'Outperform' rating.
Nutrien reported strong Q2 financials with $2.40 billion adjusted EBITDA and $10.81 billion revenue, though EPS of $2.61 missed estimates. CIBC kept an 'Outperform' rating but lowered the price target slightly to $84 from $85. The company raised its ...
